Zabedosertib

Pharmaceutical compound From Wikipedia, the free encyclopedia

Zabedosertib (BAY 1834845) is an experimental drug which acts as a selective inhibitor of the enzyme interleukin‐1 receptor‐associated kinase 4 (IRAK4). It has antiinflammatory effects and is being researched for possible applications in treating inflammatory conditions of the skin.[1][2][3]

CAS Number
Quick facts Identifiers, CAS Number ...
Zabedosertib
Identifiers
  • N-[6-(2-hydroxypropan-2-yl)-2-(2-methylsulfonylethyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
Chemical and physical data
FormulaC21H22F3N3O4S
Molar mass469.48 g·mol−1
3D model (JSmol)
  • O=S(=O)(C)CCn1nc2cc(c(NC(=O)c3cc(ccc3)C(F)(F)F)cc2c1)C(O)(C)C
  • InChI=1S/C20H21F3N4O4S/c1-19(2,29)13-10-15-12(11-27(26-15)7-8-32(3,30)31)9-16(13)25-18(28)14-5-4-6-17(24-14)20(21,22)23/h4-6,9-11,29H,7-8H2,1-3H3,(H,25,28)
  • Key:OQAMEEFUUFJZRS-UHFFFAOYSA-N
Close

See also

References

Related Articles

Wikiwand AI